Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 10;19(2):458-466.
doi: 10.5114/aoms/157308. eCollection 2023.

Menopause and women's cardiovascular health: is it really an obvious relationship?

Affiliations

Menopause and women's cardiovascular health: is it really an obvious relationship?

Kamila Ryczkowska et al. Arch Med Sci. .

Abstract

Cardiovascular diseases are common for men and women but there are differences between the sexes in terms of clinical symptoms, pathophysiology and response to the treatment. Cardiovascular diseases (CVD) in women is commonly underdiagnosed and often women tend to have a lower perception of the risk. That can lead to delayed diagnosis and failed recognition of symptoms. Women develop heart diseases later than men because of the protection in the reproductive phase of their life. Once they enter menopause the risk increases. Estrogen provides a protective effect against heart disease in women. Therefore, the risk of CVD increases after menopause in most cases. The presented work emphasizes the importance of the menopausal period as the time of increasing CVD risk. It also emphasizes the importance of monitoring the health of women in their middle age, a critical time in which early intervention strategies should be implemented to reduce the risk of CVD.

Keywords: cardiovascular diseases; estrogens; hormone therapy; hypertension; lipid disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Protective role of estrogen (E2)
Figure 2
Figure 2
Menopause and cardiovascular disease

Similar articles

Cited by

References

    1. Bajelan M, Etehad Roodi N, Hasanzadeh Daloee M, Farhangnia M, Samadi Kuchaksaraei A. The effect of low testosterone and estrogen levels on progressive coronary artery disease in men. Rep Biochem Mol Biol 2019; 8: 168-71. - PMC - PubMed
    1. Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Hear Circ Physiol 2018; 315: H1569-88. - PMC - PubMed
    1. Paduszyńska A, Banach M, Maciejewski M, Dąbrowa M, Bielecka-Dąbrowa A. The outcomes of hypertension treatment depending on gender in patients over 40 years of age. Prz Menopauz 2021; 19: 174-8. - PMC - PubMed
    1. Zhao H, Zhou L, Shangguan AJ, Bulun SE. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol 2016; 57: R19-33. - PMC - PubMed
    1. Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 2017; 8: 33. - PMC - PubMed